Full Text Journal Articles by
Author Hans H Herfarth

Advertisement

Find full text journal articles






Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.

Millie D Long, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla, Robert McCabe, Benjamin L Cohen, Ryan C Ungaro, Will Harlan, John Hanson, Gauree Konijeti, Steven Polyak, Timothy Ritter, Bruce Salzberg, Jennifer Seminerio, Emily English, Xian Zhang, Puza P Sharma, Hans H Herfarth,

<h4>Background</h4>Tofacitinib is an oral, small-molecule JAK inhibitor for the treatment of ulcerative colitis (UC). Using a novel electronic reporting tool, we aimed to prospectively describe the onset of tofacitinib efficacy during induction therapy in a real-world study.<h4>Methods</h4>Patient-reported outcome data (PROs) including the simple clinical colitis activity index (SCCAI), PRO Measurement ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2022, :izac121]

Cited: 0 times

View full text PDF listing >>



Increasing Incidence of Pouchitis Between 1996 and 2018: A Population-Based Danish Cohort Study.

Edward L Barnes, Kristine H Allin, Aske T Iversen, Hans H Herfarth, Tine Jess,

<h4>Background & aims</h4>Current knowledge regarding the epidemiology of pouchitis is based on highly selected, mostly single-center, patient cohorts. Our objective was to prospectively determine the population-based incidence of pouchitis in patients with ulcerative colitis in the first 2 years after ileal pouch-anal anastomosis and analyze time trends of the incidence ... Read more >>

Clin Gastroenterol Hepatol (Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association)
[2022, :S1542-3565(22)00440-2]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.4872 s